OIS@AAO 2014

InnFocus

InnFocus

By Tom Salemi | November 25, 2014

InnFocus Inc.’s MicroShunt glaucoma drainage implant is designed to reduce intraocular pressure in glaucoma patients. President and CEO Russell Trenary explained that the implant is…

Read More
Avedro AAO 2014

Avedro

By Tom Salemi | November 25, 2014

Avedro’s KXL® System for accelerated cross-linking, as well as a family of riboflavin products, have been commercially available since 2010. Refractive correction pioneer and veteran David…

Read More
ForSight VISION5

ForSight VISION5

By Tom Salemi | November 25, 2014

ForSight VISION5 Inc. CEO John Maroney discussed his company’s novel, non-invasive insert system, Helios. Placed on the surface of the eye, under the eyelid, Helios…

Read More
Implandata Ophthalmic Products GmbH AAO 2014

Implandata Ophthalmic Products GmbH

By Tom Salemi | November 25, 2014

Implandata Ophthalmic Products GmbH is developing a patient-operated, hand-held system, which works with an implantable micro sensor capable of measuring absolute intraocular pressure continuously or…

Read More
IOPtima AAO 2014

IOPtima

By Tom Salemi | November 25, 2014

Ronen Castro, CEO of Israeli company IOPtima Ltd., introduced the CLASS (CO2 Laser-Assisted Sclerectomy Surgery) procedure for glaucoma, which has results comparable to trabeculectomy, but…

Read More
Mati Therapeutics AAO 2014

Mati Therapeutics

By Tom Salemi | November 25, 2014

Mati Therapeutics Inc. is an early-stage company addressing the massive glaucoma market. Founder and CEO Robert Butchofsky discussed the main challenges to all glaucoma-focused sustained…

Read More
Neurotech AAO 2014

Neurotech

By Tom Salemi | November 25, 2014

Quinton Oswold, President and CEO of Neurotech Pharmaceuticals Inc., sees huge opportunity both in wet AMD and diabetic macular edema patients who need more extensive…

Read More
PowerVision AAO 2014

PowerVision

By Tom Salemi | November 25, 2014

PowerVision Inc.’s FluidVision, an intraocular lens designed to treat presbyopia and/or cataracts, is the only technology that restores true accommodation, reported company President and CEO…

Read More
TearScience AAO 2014

TearScience

By Tom Salemi | November 25, 2014

TearScience Inc. CEO and Co-Founder Tim Willis emphasized that his company was founded for a single reason: to be the evaporative dry eye expert, and…

Read More
WaveTec Vision Systems AAO 2014

WaveTec Vision Systems

By Tom Salemi | November 25, 2014

WaveTec Vision Systems ORA system is the first intra-operative diagnostic tool on the market to enhance visual outcomes in cataract surgery. It allows surgeons, in…

Read More
Alimera Sciences

Alimera Sciences

By Tom Salemi | November 14, 2014

Alimera Sciences Inc. is ready to launch in the US its recently approved intravitreal implant, Iluvien, for treating diabetic macular edema. President and CEO Dan…

Read More
MC2 Biotek Group Offers Insights on PAD

MC2 Biotek Group Offers Insights on PAD

By Tom Salemi | November 7, 2014

MC2 Biotek Group’s Co-Founder and President Jesper J. Lange updated attendees on the company’s PAD technology, which may make existing drugs easier to use. The…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.